secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0001641172-25-002750
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma issues pre-funded warrant to Cytovance for 326,251 shares as service consideration
--------------------------------------------------------------------------------

- Issued pre-funded warrant to purchase up to 326,251 shares of common stock at $0.0001 per share.
- Aggregate exercise price of $846,562.50 was pre-funded via services rendered by Cytovance Biologics.
- Warrant is immediately exercisable with a beneficial ownership limitation; no cash received.
- Issued without registration under Section 4(a)(2) of Securities Act as a private transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000164117225002750/0001641172-25-002750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000164117225002750/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer